GTS400 Stent Implantation in Conjunction With Cataract Surgery in Subjects With Open-angle Glaucoma

Status:	Archived
Conditions:	Ocular
Therapuetic Areas:	Ophthalmology
Healthy:	No
Age Range:	Any
Updated:	7/1/2011
Start Date:	January 2010
End Date:	August 2013

A Prospective, Randomized, Controlled, Parallel Groupos, Multicenter Clinical Investigation of the Glaukos Trabecular Micro-bypass Stent Model GTS400 in Conjunction With Cataract Surgery

The purpose of this study is to evaluate the safety and efficacy of the GTS400 trabecular
micro-bypass stent in reducing intraocular pressure (IOP) in subjects with open-angle
glaucoma or ocular hypertension and co-existing cataract.

Glaucoma is a collection of disorders characterized by progressive loss of visual field due
to optic nerve damage. It is a leading cause of blindness in the United States, affecting
1-2% of individuals aged 60 and over. Management of glaucoma requires chronic, life-long
treatment with a spectrum of therapeutic options including medications, laser treatment and
surgical implants. The common goal among the various therapies is to lower intraocular
pressure to target levels in order to prevent loss of visual fields from excessive pressure
on the optic nerve.

We found this trial at

sites

St John's Medical Research Institute

Springfield, Missouri 65807

from

Springfield, MO